Crossmark

Does completion time of the initiation phase of anti-vascular growth factor affect visual and anatomical outcomes?: The MARMASIA study group report No.5

Crossref DOI link: https://doi.org/10.1038/s41433-025-03928-6

Published Online: 2025-07-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aydoğan Gezginaslan, Tuğba https://orcid.org/0000-0002-2624-7496
Özkaya, Abdullah

Sevik, Mehmet Orkun https://orcid.org/0000-0001-7130-4798
Saygın, Işılay Özsoy

Limon, Utku https://orcid.org/0000-0002-4998-1896
Bozkurt, Erdinç https://orcid.org/0000-0002-5570-799X
Önder Tokuç, Ecem

Başaran Emengen, Ece

Kutlutürk Karagöz, Işıl

Kanar, Hatice Selen

Aykut, Aslan

Açıkalın Öncel, Banu

Kaplan, Fatih Bilgehan

Sönmez, Ayşe Demirciler

Çelik, Erkan

Yayla, Uğur

Yenerel, Nursal Melda

Aydın Öncü, Özlem

Türkseven Kumral, Esra

Erçalık, Nimet Yeşim

Şahin, Özlem

Karabaş, Levent
License Information

Text and Data Mining valid from 2025-07-15

Version of Record valid from 2025-07-15
More Information

Article History

Received: 15 April 2024

Revised: 11 June 2025

Accepted: 3 July 2025

First Online: 15 July 2025

Competing interests

: The authors declare that there is no conflict of interests. All authors attest that they meet the current ICMJE criteria for authorship.

Document is current

Any future updates will be listed below